The US Food and Drug Administration (FDA) is planning to hold a meeting over a highly contentious issue this month - whether genetically engineered salmon should be the first animal of its kind to be sold as food.
The results of this consultation will have a significant impact on the food industries of both the UK and the US, as well as for those in food jobs at every stage of the food manufacturing process.
The Veterinary Medicine Advisory Committee will convene for the FDA meeting - scheduled to take place on September 19th - 20th 2010 - to review current scientific data and compile recommendations on whether GM salmon is fit for the dinner table. The FDA will also hold a public consultation on the issue on September 21st, which will be crucial to whether plans go ahead.
AquaBounty Technologies Inc
The salmon in question is developed by Massachusetts-based AquaBounty Technologies Inc, who claims that the salmon is able to avoid the disease and pollution commonly associated with salmon raised in fish farms, and can also grow to market size and weight twice as fast.
Opposition
Food safety experts and consumer rights advocates are against the idea of selling GM salmon as food as the side effects of eating the fish are still unknown, and there is no evidence to show that it is safe.
